Olive oil to lower heart risk in people with HIV
Part of Immune system & allergy, Infections clinical trials.
This study tests whether adding extra virgin olive oil to the diet can reduce the chance of heart attacks, strokes, or other heart problems in adults living with HIV. Participants will either follow a Mediterranean diet with extra olive oil or continue their usual diet for several years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 50 and 75 years old
- Have HIV-1 for at least one year
- Be on antiretroviral therapy (ART) with a viral load under 50 copies/mL for at least 6 months (some exceptions apply)
- Have at least one heart risk factor, such as high blood pressure, diabetes, high cholesterol, smoking, or a family history of early heart disease
- Be willing to change your diet and consume extra virgin olive oil (if assigned to that group)
- Not have a history of heart disease, stroke, or serious conditions like cirrhosis, kidney failure, or cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a natural compound in olive oil (called erythrodiol) can help protect against atherosclerosis, which is the buildup of plaque in arteries. The goal is to see if this oil can keep your blood vessels healthy and reduce heart disease risk.
This study looks at how hidden fat deep inside the body (ectopic fat) might increase heart attack risk in people living with HIV. By joining, you will help researchers understand this link and find better ways to protect your heart.
This trial tests if a drug can lower inflammation in people with HIV who are on effective treatment. It may help reduce the risk of heart disease and other problems related to chronic inflammation.
This study tests whether a daily supplement called genistein, derived from soy, can help reduce the risk of heart problems in people living with HIV. It aims to see if genistein can improve blood vessel function and lower inflammation, potentially protecting your heart.
This study looks at how a structured exercise program affects the heart and blood flow in people living with HIV. It may help your care team understand who benefits most from exercise and how to do it safely.
This trial tests if colchicine, a medicine for inflammation, can reduce swelling in the heart arteries of people with HIV. It may help lower the risk of heart problems in those already on a statin or similar medication.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.